Morgan Stanley upgrades insurer Lemonade to 'equal-weight'
- Gold remains bid as lack of Fed clarity and geopolitical frictions persist
- U.S. November Nonfarm Payrolls: What Does the Rare "Weak Jobs, Strong Economy" Mix Mean for U.S. Equities?
- Tesla Stock Hits Record High as Robotaxi Tests Ignite Market. Why Is Goldman Sachs Pouring Cold Water on Tesla?
- U.S. November CPI: How Will Inflation Fluctuations Transmit to US Stocks? Tariffs Are the Key!
- AUD/USD remains depressed below mid-0.6600s; downside seems limited ahead of US NFP report
- December Santa Claus Rally: New highs in sight for US and European stocks?

Investing.com - Morgan Stanley on Wednesday said it was upgrading insurer Lemonade Inc (NYSE:LMND) to "equal-weight" from "underweight" and raised its price target to $42 from $23.
Shares of Lemonade rose 17.2% at $47, with stock more than doubled in value year to date.
Lemonade at its investor day unveiled plan to grow its business from $1 billion in premiums to $10 billion over the next few years.
The insurance technology company plans to achieve these goals by leveraging advanced technology, improving operational efficiency, and focusing on auto insurance growth. Lemonade's updated guidance also projects a 30% annual growth rate in in-force premiums (IFP), reaching $2 billion by 2027.
Morgan Stanley (NYSE:MS) cited optimism about the company’s profitability timeline, which surpasses market expectations. The bank highlighted Lemonade’s plans for significant expense efficiencies as key to hitting these targets.
For 2025, Lemonade forecasts 50% adjusted gross profit growth, $1.2 billion in IFP, and positive adjusted free cash flow, despite operating in an increasingly competitive auto insurance market.
While Morgan Stanley the most important element of the investor day for it was the goal to achieve net profit exiting 2027, which is significantly better than Wall Street consensus and its expectations.
Read more
* The content presented above, whether from a third party or not, is considered as general advice only. This article should not be construed as containing investment advice, investment recommendations, an offer of or solicitation for any transactions in financial instruments.

